---
document_datetime: 2023-09-21 19:05:09
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/sancuso-epar-all-authorised-presentations_en.pdf
document_name: sancuso-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.72567
conversion_datetime: 2025-12-28 03:22:24.313267
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | (Invented)   | Strength      | Pharmaceutical    | Route of        | Packaging                       | Package size   |
|-----------------|--------------|---------------|-------------------|-----------------|---------------------------------|----------------|
|                 | name         |               | Form              | Administration  |                                 |                |
| EU/1/12/766/001 | Sancuso      | 3.1 mg / 24 h | Transdermal patch | Transdermal use | sachet (coated paper/alu/LLDPE) | 1 patch        |